Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor.

Mata MA, Satterly N, Versteeg GA, Frantz D, Wei S, Williams N, Schmolke M, Peña-Llopis S, Brugarolas J, Forst CV, White MA, García-Sastre A, Roth MG, Fontoura BM.

Nat Chem Biol. 2011 Sep 11;7(10):712-9. doi: 10.1038/nchembio.645.

2.

APOBEC3G-Regulated Host Factors Interfere with Measles Virus Replication: Role of REDD1 and Mammalian TORC1 Inhibition.

Tiwarekar V, Wohlfahrt J, Fehrholz M, Scholz CJ, Kneitz S, Schneider-Schaulies J.

J Virol. 2018 Aug 16;92(17). pii: e00835-18. doi: 10.1128/JVI.00835-18. Print 2018 Sep 1.

3.

Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner.

Walkiewicz MP, Basu D, Jablonski JJ, Geysen HM, Engel DA.

J Gen Virol. 2011 Jan;92(Pt 1):60-70. doi: 10.1099/vir.0.025015-0. Epub 2010 Sep 29.

4.

Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor.

Tawaratsumida K, Phan V, Hrincius ER, High AA, Webby R, Redecke V, Häcker H.

J Virol. 2014 Aug;88(16):9038-48. doi: 10.1128/JVI.00830-14. Epub 2014 Jun 4.

5.

Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.

Hsu JT, Yeh JY, Lin TJ, Li ML, Wu MS, Hsieh CF, Chou YC, Tang WF, Lau KS, Hung HC, Fang MY, Ko S, Hsieh HP, Horng JT.

Antimicrob Agents Chemother. 2012 Feb;56(2):647-57. doi: 10.1128/AAC.00125-11. Epub 2011 Sep 19.

6.

HIV-protease inhibitors block the replication of both vesicular stomatitis and influenza viruses at an early post-entry replication step.

Federico M.

Virology. 2011 Aug 15;417(1):37-49. doi: 10.1016/j.virol.2011.05.002. Epub 2011 May 28.

7.

Antiviral activity of doxycycline against vesicular stomatitis virus in vitro.

Wu ZC, Wang X, Wei JC, Li BB, Shao DH, Li YM, Liu K, Shi YY, Zhou B, Qiu YF, Ma ZY.

FEMS Microbiol Lett. 2015 Nov;362(22). pii: fnv195. doi: 10.1093/femsle/fnv195. Epub 2015 Oct 12.

PMID:
26459887
8.

Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.

Baughman BM, Jake Slavish P, DuBois RM, Boyd VA, White SW, Webb TR.

ACS Chem Biol. 2012 Mar 16;7(3):526-34. doi: 10.1021/cb200439z. Epub 2012 Jan 19.

9.

Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export.

Zhang L, Das P, Schmolke M, Manicassamy B, Wang Y, Deng X, Cai L, Tu BP, Forst CV, Roth MG, Levy DE, García-Sastre A, de Brabander J, Phillips MA, Fontoura BM.

J Cell Biol. 2012 Feb 6;196(3):315-26. doi: 10.1083/jcb.201107058.

10.

Identification of a broad-spectrum inhibitor of viral RNA synthesis: validation of a prototype virus-based approach.

Filone CM, Hodges EN, Honeyman B, Bushkin GG, Boyd K, Platt A, Ni F, Strom K, Hensley L, Snyder JK, Connor JH.

Chem Biol. 2013 Mar 21;20(3):424-33. doi: 10.1016/j.chembiol.2013.02.011.

11.

Novel influenza virus NS1 antagonists block replication and restore innate immune function.

Basu D, Walkiewicz MP, Frieman M, Baric RS, Auble DT, Engel DA.

J Virol. 2009 Feb;83(4):1881-91. doi: 10.1128/JVI.01805-08. Epub 2008 Dec 3.

12.

Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.

Shih SR, Chu TY, Reddy GR, Tseng SN, Chen HL, Tang WF, Wu MS, Yeh JY, Chao YS, Hsu JT, Hsieh HP, Horng JT.

J Biomed Sci. 2010 Feb 23;17:13. doi: 10.1186/1423-0127-17-13.

13.

Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma.

Kucejova B, Peña-Llopis S, Yamasaki T, Sivanand S, Tran TA, Alexander S, Wolff NC, Lotan Y, Xie XJ, Kabbani W, Kapur P, Brugarolas J.

Mol Cancer Res. 2011 Sep;9(9):1255-65. doi: 10.1158/1541-7786.MCR-11-0302. Epub 2011 Jul 28.

14.

Small interfering RNA targeting the nonstructural gene 1 transcript inhibits influenza A virus replication in experimental mice.

Rajput R, Khanna M, Kumar P, Kumar B, Sharma S, Gupta N, Saxena L.

Nucleic Acid Ther. 2012 Dec;22(6):414-22. doi: 10.1089/nat.2012.0359. Epub 2012 Oct 12.

PMID:
23062009
15.
16.

Potent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerases.

Krumm SA, Ndungu JM, Yoon JJ, Dochow M, Sun A, Natchus M, Snyder JP, Plemper RK.

PLoS One. 2011;6(5):e20069. doi: 10.1371/journal.pone.0020069. Epub 2011 May 16.

17.

Inhibition of hepatitis C virus infection by polyoxometalates.

Qi Y, Xiang Y, Wang J, Qi Y, Li J, Niu J, Zhong J.

Antiviral Res. 2013 Nov;100(2):392-8. doi: 10.1016/j.antiviral.2013.08.025. Epub 2013 Sep 8.

PMID:
24025401
18.

Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1.

Jablonski JJ, Basu D, Engel DA, Geysen HM.

Bioorg Med Chem. 2012 Jan 1;20(1):487-97. doi: 10.1016/j.bmc.2011.10.026. Epub 2011 Oct 19.

19.

Antiviral effect of octyl gallate against influenza and other RNA viruses.

Yamasaki H, Uozaki M, Katsuyama Y, Utsunomiya H, Arakawa T, Higuchi M, Higuti T, Koyama AH.

Int J Mol Med. 2007 Apr;19(4):685-8.

PMID:
17334645
20.

Influenza virus non-structural protein NS1: interferon antagonism and beyond.

Marc D.

J Gen Virol. 2014 Dec;95(Pt 12):2594-611. doi: 10.1099/vir.0.069542-0. Epub 2014 Sep 2. Review.

PMID:
25182164

Supplemental Content

Support Center